Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

6 clinical studies listed.

Filters:

Chronic Kidney Disease Stage 3B

Tundra lists 6 Chronic Kidney Disease Stage 3B clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07901621

Combined Versus Multicomponent Training in People With Chronic Kidney Disease Stages 3a and 3b

This randomized controlled trial will compare the effects of 12 weeks of combined training (aerobic plus resistance exercise) and multicomponent training (aerobic plus resistance plus balance exercise) with a control group without supervised exercise in adults aged 55 to 70 years with chronic kidney disease (CKD) stages 3a or 3b who are not on dialysis. Fifty-seven participants will be randomly allocated (1:1:1) to one of the three groups. Supervised training sessions will last 60 minutes and will be held three times a week at the University of Brasilia, Brazil. The main questions are whether these programs improve peak oxygen uptake, resting blood pressure, physical health-related quality of life, and estimated glomerular filtration rate, and whether adding balance exercises provides additional benefits for balance, falls, and functional capacity.

Gender: All

Ages: 55 Years - 70 Years

Updated: 2026-10-30

1 state

Chronic Kidney Disease Stage 3A
Chronic Kidney Disease Stage 3B
Chronic Kidney Disease, Non-dialysis
COMPLETED

NCT05489120

Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

The KDOQI 2020 - Clinical practice guideline for nutrition in chronic kidney disease (CKD) -recommends protein restriction to reduce the risk of end-stage renal disease/death and improve quality of life, a low protein diet providing 0.55-0.60g dietary protein/ kg body weight/day is recommended. FLAVIS® is a product line of hypoprotein foods specially developed for the treatment of CKD.The use of low-protein foods may facilitate the achievement of nutritional goals in terms of protein intake and help patients to follow a low-protein diet.

Gender: All

Ages: 18 Years - Any

Updated: 2026-08-17

Chronic Kidney Disease Stage 3B
Chronic Kidney Disease stage4
Chronic Kidney Disease Stage 5
+1
TERMINATED

NCT04330807

Physiopathology of Neuromuscular Function Related to Fatigue in Chronic Renal Disease

Chronic Kidney Disease (CKD) induces many metabolic troubles especially for the advanced CKD (stage 3b-5) patients and their prevalence and importance grow with the deterioration of the glomerular filtration rate (GFR). Among them, muscle wasting is common and multifactorial, partially explained by an imbalance between protein catabolism and synthesis. Muscular strength is also affected beyond the reduction of the lean body mass, resulting in profound fatigue. The present study seeks to quantify the prevalence of low muscular strength production (dynapenia) in a cohort of elderly patients with advanced CKD, through a maximal voluntary contraction (MVC) handgrip test compared to control data available in the literature, matched in term of age and sex. It also aims to investigate the link between the reported fatigue (subjective) and the evolution of the MVC, called critical force (fcrit) during a fatiguing task (objective fatigability).

Gender: All

Ages: 60 Years - Any

Updated: 2026-07-01

Chronic Kidney Disease Stage 3B
Chronic Kidney Disease stage4
Chronic Kidney Disease Stage 5
+1
ACTIVE NOT RECRUITING

NCT06394544

Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment

The aim of this study is to evaluate the effects of Brazil nut supplementation on inflammation, oxidative stress and intestinal microbiota in patients with chronic kidney disease undergoing conservative treatment.

Gender: All

Ages: 20 Years - 59 Years

Updated: 2026-05-18

1 state

Chronic Kidney Diseases
Chronic Kidney Disease stage3
Chronic Kidney Disease Stage 3A
+6
NOT YET RECRUITING

NCT06760650

Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease

Our study hypothesizes that fluorescein exposure in diabetic patients with advanced chronic kidney disease results in deterioration of kidney function. It will therefore aim to evaluate the incidence of acute kidney injury induced by fluorescein in diabetic patients with CKD. The objective is to determine the incidence, severity and risk factors associated with this deterioration to improve the care of this specific population.

Gender: All

Ages: 18 Years - Any

Updated: 2025-01-07

Chronic Kidney Disease Stage 4
Chronic Kidney Disease Stage 3B
Chronic Kidney Disease Stage 5
+3
NOT YET RECRUITING

NCT04827290

Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease

Normal-protein and low-AGE through raw or rare proteins diet versus normal-protein and high-AGE diet in stage IIIa-b renal failure patients

Gender: All

Ages: 18 Years - 89 Years

Updated: 2024-04-04

Kidney Failure, Chronic
Chronic Kidney Disease stage3
Chronic Kidney Disease Stage 3B
+3